Research ArticleLaboratory Studies
In Vitro Identification of Vasoactive Intestinal Peptide Receptors in Human Tumors: Implications for Tumor Imaging
Jean Claude Reubi
Journal of Nuclear Medicine October 1995, 36 (10) 1846-1853;


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
In Vitro Identification of Vasoactive Intestinal Peptide Receptors in Human Tumors: Implications for Tumor Imaging
Jean Claude Reubi
Journal of Nuclear Medicine Oct 1995, 36 (10) 1846-1853;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
- The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues
- PET Imaging of Oncogene Overexpression Using 64Cu-Vasoactive Intestinal Peptide (VIP) Analog: Comparison with 99mTc-VIP Analog
- SST3-selective potent peptidic somatostatin receptor antagonists
- Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers
- Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone
- Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-activating Peptide Receptor Subtypes in Human Tumors and Their Tissues of Origin1
- Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions
- Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro
- Regulatory peptide receptors in human hepatocellular carcinomas
- Gastrin-releasing Peptide Receptors in the Human Prostate: Relation to Neoplastic Transformation
- Localization of Receptors for Vasoactive Intestinal Peptide, Somatostatin, and Substance P in Distinct Compartments of Human Lymphoid Organs
- Stabilization of Vasoactive Intestinal Peptide by Lipids
- Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone
- SST3-selective potent peptidic somatostatin receptor antagonists
- Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers